Amgen's (JOBS) Bone Drug May Face Delays In FDA Decision
Published: Oct 16, 2009
NEW YORK (Dow Jones)--Biotech investors had circled Oct. 19 as the day that Amgen Inc.'s (AMGN) osteoporosis drug denosumab gets approved, but they may have to wait longer.